Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds.

× No keyword cloud information.

19 in total

1. Experimental toxicology of ASTA Z 7557 (INN mafosfamide).

Authors: J Pohl; P Hilgard; W Jahn; H J Zechel
Journal: Invest New Drugs Date: 1984 Impact factor: 3.850

2. Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent.

Authors: O Tofanetti; E Cavalletti; A Besati; G Pratesi; G Pezzoni; F Zunino
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

3. Cyclophosphamide cystitis as a model of visceral pain in rats: minor effects at mesodiencephalic levels as revealed by the expression of c-fos, with a note on Krox-24.

Authors: K Bon; M Lantéri-Minet; J de Pommery; J F Michiels; D Menétrey
Journal: Exp Brain Res Date: 1997-02 Impact factor: 1.972

4. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.

Authors: H Jürgens; U Exner; J Kühl; J Ritter; J Treuner; P Weinel; K Winkler; U Göbel
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

5. Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors: Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal: Am J Physiol Renal Physiol Date: 2013-11-27

Review 6. Dosing and side-effects of ifosfamide plus mesna.

Authors: W P Brade; K Herdrich; U Kachel-Fischer; C E Araujo
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

7. Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats.

Authors: Sukru Oter; Ahmet Korkmaz; Emin Oztas; Ibrahim Yildirim; Turgut Topal; Hayati Bilgic
Journal: Urol Res Date: 2004-01-31

8. Ifosfamide chemotherapy for pancreatic carcinoma.

Authors: L H Einhorn; P J Loehrer
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

9. Ideas and reality in the development of cancer chemotherapeutic agents, with particular reference to oxazaphosphorine cytostatics.

Authors: N Brock
Journal: J Cancer Res Clin Oncol Date: 1986 Impact factor: 4.553

10. L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.

Authors: J C Roberts; D J Francetic; R T Zera
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333